These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications. Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993 [TBL] [Abstract][Full Text] [Related]
9. BCR-PDGFRA fusion in a T lymphoblastic leukemia/lymphoma. Yigit N; Wu WW; Subramaniyam S; Mathew S; Geyer JT Cancer Genet; 2015; 208(7-8):404-7. PubMed ID: 26095243 [TBL] [Abstract][Full Text] [Related]
10. Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma. Huang YH; Wan CL; Dai HP; Xue SL Ann Hematol; 2023 Aug; 102(8):2001-2013. PubMed ID: 37227492 [TBL] [Abstract][Full Text] [Related]
11. A novel FIP1L1-PDGFRA mutant destabilizing the inactive conformation of the kinase domain in chronic eosinophilic leukemia/hypereosinophilic syndrome. Salemi S; Yousefi S; Simon D; Schmid I; Moretti L; Scapozza L; Simon HU Allergy; 2009 Jun; 64(6):913-8. PubMed ID: 19210352 [TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of novel oncogenes in chronic eosinophilic leukemia and T-cell acute lymphoblastic leukemia. Cools J Verh K Acad Geneeskd Belg; 2010; 72(1-2):55-70. PubMed ID: 20726440 [TBL] [Abstract][Full Text] [Related]
13. Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma. DuVall AS; Wesevich A; Larson RA Curr Hematol Malig Rep; 2023 Dec; 18(6):217-225. PubMed ID: 37490229 [TBL] [Abstract][Full Text] [Related]
14. Analysis of 60 patients with relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma treated with CD7-targeted chimeric antigen receptor-T cell therapy. Zhang X; Yang J; Li J; Qiu L; Zhang J; Lu Y; Zhao YL; Jin D; Li J; Lu P Am J Hematol; 2023 Dec; 98(12):1898-1908. PubMed ID: 37740926 [TBL] [Abstract][Full Text] [Related]
15. Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma. De Coninck S; De Smedt R; Lintermans B; Reunes L; Kosasih HJ; Reekmans A; Brown LM; Van Roy N; Palhais B; Roels J; Van der Linden M; Van Dorpe J; Ntziachristos P; Van Delft FW; Mansour MR; Pieters T; Lammens T; De Moerloose B; De Bock CE; Goossens S; Van Vlierberghe P Haematologica; 2024 May; 109(5):1373-1384. PubMed ID: 37941480 [TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy comparison of avapritinib with other tyrosine kinase inhibitors in gastrointestinal stromal tumors with PDGFRA D842V mutation: a retrospective analysis of clinical trial and real-world data. von Mehren M; Heinrich MC; Shi H; Iannazzo S; Mankoski R; Dimitrijević S; Hoehn G; Chiroli S; George S BMC Cancer; 2021 Mar; 21(1):291. PubMed ID: 33740926 [TBL] [Abstract][Full Text] [Related]
17. Case Report: Pediatric myeloid/lymphoid neoplasm with eosinophilia and PDGFRA rearrangement: The first case presenting as B-lymphoblastic lymphoma. Akiely R; Almasri F; Almasri N; Abu-Ghosh A Front Pediatr; 2022; 10():1059527. PubMed ID: 36589160 [TBL] [Abstract][Full Text] [Related]
18. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma. Salmerón-Villalobos J; Ramis-Zaldivar JE; Balagué O; Verdú-Amorós J; Celis V; Sábado C; Garrido M; Mato S; Uriz J; Ortega MJ; Gutierrez-Camino A; Sinnett D; Illarregi U; Carron M; Regueiro A; Galera A; Gonzalez-Farré B; Campo E; Garcia N; Colomer D; Astigarraga I; Andrés M; Llavador M; Martin-Guerrero I; Salaverria I Pediatr Blood Cancer; 2022 Nov; 69(11):e29926. PubMed ID: 36000950 [TBL] [Abstract][Full Text] [Related]
19. Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma. De Smedt R; Morscio J; Reunes L; Roels J; Bardelli V; Lintermans B; Van Loocke W; Almeida A; Cheung LC; Kotecha RS; Mansour MR; Uyttebroeck A; Vandenberghe P; La Starza R; Mecucci C; Lammens T; Van Roy N; De Moerloose B; Barata JT; Taghon T; Goossens S; Van Vlierberghe P Blood; 2020 May; 135(19):1685-1695. PubMed ID: 32315407 [TBL] [Abstract][Full Text] [Related]
20. Design of a targeted next-generation DNA sequencing panel for pediatric T-cell lymphoblastic lymphoma to unravel biology and optimize treatment. Ruether C; Wuensch C; Randau G; Michgehl U; Trautmann M; Hartmann W; Sandmann S; Dugas M; Khanam T; Burkhardt B Genes Chromosomes Cancer; 2022 Aug; 61(8):459-470. PubMed ID: 35278000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]